Publications

Dr Evan Papanastasiou | MD MSc PhD MBA

Selected Published Articles - PhD & MBA Theses

 
 
 

Prodromal Psychosis

Published original research.

 
 
 

Schizophrenia

Published Systematic Reviews & Meta-Analyses.

Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials. Meta-Analysis, Schizophrenia Bulletin, 2015.

When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia. Discussion Article, British Journal of Psychiatry, 2013.

The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review. Focused Review, Therapeutic Advances in Psychopharmacology, 2012.

Interventions for the metabolic syndrome in schizophrenia: a review. Focused Review, Therapeutic Advances in Endocrinology and Metabolism, 2012.

Schizophrenia as Segmental Progeria. Discussion Article, Journal of the Royal Society of Medicine, 2011.

 
 
 

CNS Drug Development

Published articles.

Precision Psychiatry RDoC Conceptualization. Discussion Article, CNS Spectrums, 2023

fMRI Trials in Schizophrenia. Letter to the Editor, Journal of Psychopharmacology, 2021.

A Touch of Pragmatism in Clinical Trials. Selective Review, Journal for Clinical Studies, 2017.

 
 
 

Behavioural Finance

MBA related work.

Investors’ responses to pharmaceutical announcements of interest. MBA Thesis submitted at the American College of Thessaloniki, 2021.

 
 
 

Full Research Profile

Visit us at ORCID:

ORCID iD 0000-0002-8029-666X

ORCID iD 0000-0002-8029-666X